The global drug eluting balloons market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Drug eluting balloons are also referred to as drug-coated balloons and have been one of the promising forms of new transcatheter technologies that has been aimed to reduce high restenosis rates in coronary heart diseases and peripheral artery disease. Thus, the growing prevalence of the diseases such coronary heart diseases, peripheral artery disease, coupled with the rising prevalence of obesity is likely to spur the demand for drug eluting balloons all over the globe. Since drug eluting balloons are semi-compliant angioplasty balloons coated with anti-proliferative medications, their controlled form of drug delivery has made them one of the most effective technological inventions in the medical sector. 

The medication is delivered to the walls of blood arteries that follow the balloon inflation, typically done at minimal pressures. This further reduces cellularity and alleviates the need for repeated vascularization. Due to such increased product advancements in recent years, drug eluting balloons have emerged as a potential option to fight against restenosis. Paclitaxel was discovered as the primary drug for drug eluting balloons owing to its rapid uptake and prolonged retention. The growth of the global drug eluting balloons market is also attributed to the growing prevalence of cardiovascular diseases and rising elderly population. According to the World Heart Federation, in the US, the most frequent type of heart illness is coronary heart disease, that affects approximately 18.2 million persons aged 20 and up (about 6.7%). Such high prevalence of coronary heart disease is likely to boost the growth of the global drug eluting balloons market.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028

Segment Covered- 

• By Product
• By Technology

Regions covered-

• North America
• Europe
• Asia-Pacific
• Rest of the World

Competitive Landscape:  Medtronic plc, Boston Scientific Corp., and Terumo Corp., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Drug Eluting Balloons Market Report by Segment

By Product

• Coronary Drug Eluting Balloon
• Peripheral Drug Eluting Balloon
• Others

By Technology

• FreePac
• TransPax
• EnduraCoat
• Others

Global Drug Eluting Balloons Market Report by Region

North America       

• US
• Canada

Europe

• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific    

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East and Africa